Cynvenio Ties Into Cancer Trials In Denmark

Westlake Village-based cancer diagnostics developer Cynvenio Biosystems is in a collaboration to conduct an array of clinical cancer trials, at the University of Southern Denmark, the company said yesterday. According to Cynvenio, the strategic collaboration is with the Institute of Regional Health Research for the Region of Southern Denmark at the University of Southern Denmark, and involves studies on colorectal and breast cancer patients. The studies will involve use of Cynvenio's LiquidBiopsy PD-L1 assay, which is used to detect circulating cancer cells in a patient's blood stream.